Work

Phase II clinical trial of atezolizumab (A) in advanced non-small cell lung cancer (NSCLC) patients (pts) previously treated with PD1-directed therapy.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.tps9105

Authors: Saveri Bhattacharya, Cindy Yun, Katja Schulze, Tullia C. Bruno, Brenda F Kurland, Mark A. Socinski, Liza Cosca Villaruz

Institutions: UPMC Hillman Cancer Center, Genentech, University of Pittsburgh, Florida Hospital Cancer Institute

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2626321828

Cites:

Cited by:

Related to: 10